NOVARTIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.37 CHF | +0.81% |
|
+0.32% | +10.02% |
| May. 16 | Dpa-AFX Overview: COMPANIES from 16.05.2024 - 15:15 | DP |
| May. 16 | Novartis: presents results of tender offer for MorphoSysy | CF |
ETFs positioned on Novartis AG
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.51% | 786 M€ | -.--% | ||
| 0.51% | 23 M€ | -.--% | - | |
| 0.50% | 206 M€ | -.--% | ||
| 0.48% | 205 M€ | -.--% | ||
| 0.47% | 727 M€ | +9.87% | ||
| 0.39% | 283 M€ | +21.31% | ||
| 0.37% | 1,166 M€ | +0.26% | - | |
| 0.37% | 607 M€ | +0.05% | - | |
| 0.30% | 36 M€ | +3.30% | - | |
| 0.26% | 391 M€ | +9.67% | - | |
| 0.23% | 34 M€ | +9.12% | - | |
| 0.22% | 0 M€ | 0.00% | - | |
| 0.21% | 45 M€ | 0.00% | - | |
| 0.17% | 306 M€ | +6.54% | - | |
| 0.17% | 39 M€ | +6.43% | - | |
| 0.13% | 105 M€ | +4.05% | - | |
| 0.12% | 17 M€ | +3.40% | - | |
| 0.09% | 34 M€ | +4.49% | - | |
| 0.08% | 234 M€ | +6.81% | - | |
| 0.06% | 54 M€ | +0.94% | - | |
| 0.06% | 8 M€ | +1.17% | - |
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows:
- oncology (29.9%);
- immunology (17.2%);
- cardiovascular, renal and metabolic diseases (14.1%);
- neuroscience (8.9%).
The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products.
At the end of 2023, Novartis AG had 33 production sites worldwide.
Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.9
USD
Average target price
108
USD
Spread / Average Target
+4.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.02% | 209B | |
| +34.35% | 705B | |
| +29.39% | 583B | |
| -3.49% | 364B | |
| +20.15% | 332B | |
| +6.19% | 291B | |
| +14.11% | 238B | |
| -3.03% | 210B | |
| +9.21% | 169B | |
| -0.90% | 162B |
- Stock Market
- Equities
- NOVN Stock
- Funds and ETFs Novartis AG